Form 4: Orgenesis Inc. Director Yaron Adler Acquires Stock Options

Director Yaron Adler of Orgenesis Inc. was granted 1,750 stock options under the company's 2017 Equity Incentive Plan.

Summary

• Yaron Adler, a director at Orgenesis Inc., was granted 1,750 stock options on December 12, 2024.
• These options were awarded under the company's 2017 Equity Incentive Plan.
• The options have an exercise price of $0.98 per share.
• The options vest one year from the grant date, on December 12, 2025, subject to continued service on the Board of Directors.
• The options expire on December 12, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally viewed as a positive sign of alignment between management and shareholders. There is no indication of any negative or unusual activity.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting period encourages continued service and commitment from the director.

Industry Context

This is a standard practice for incentivizing board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders.
• The vesting period of one year is typical for such grants, ensuring continued service and commitment from the director.
• The exercise price of $0.98 is likely based on the current market price of the stock at the time of the grant.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making and increased shareholder value.

Key Dates

Keywords

stock options, equity incentive plan, director, Orgenesis Inc., insider trading, beneficial ownership